Question 1

Does Jones Financial Companies own SLN stock?

Accepted Answer

Yes. As of its Q3 2026 13F, Jones Financial Companies holds 2,500 shares of SLN (Silence Therapeutics), worth $27,950.

Question 2

How many shares of SLN does Jones Financial Companies own?

Accepted Answer

As of its Q3 2026 13F, Jones Financial Companies holds 2,500 shares of SLN (Silence Therapeutics).

Question 3

What is Jones Financial Companies' SLN position worth?

Accepted Answer

As of its Q3 2026 13F, Jones Financial Companies' SLN position is worth $27,950.

Question 4

When did Jones Financial Companies first buy SLN?

Accepted Answer

Jones Financial Companies first reported SLN in its Q1 2025 13F and has listed it in 7 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Unchanged	2,500	0.0%	$27,950	0.0%	$10.93	0
2026-Q2	Unchanged	2,500	0.0%	$25,350	0.0%	$10.98	0
2026-Q1	Unchanged	2,500	0.0%	$12,325	0.0%	$5.27	0
2025-Q4	Unchanged	2,500	0.0%	$15,200	0.0%	$6.08	0
2025-Q3	Unchanged	2,500	0.0%	$13,850	0.0%	$5.19	0
2025-Q2	Unchanged	2,500	0.0%	$14,475	0.0%	$5.80	0
2025-Q1	New	2,500	—	$8,600	0.0%	$2.82	25